J&JCC Group offers unprecedented success for clients navigating Regulatory Compliance during the COVID-19 Pandemic. Irvine, California, January 12, 2022, J&JCC Group, a leading consulting firm, offers […]
The Food and Drug Administration (FDA) has recently announced its intention to “explore clear and meaningful measures to make tobacco products less toxic, appealing and addictive. […]
Nicotine Addictiveness Warning Statement Beginning August 10, 2018, FDA will enforce a new nicotine warning Statement. Manufacturers and distributors cannot package, sell, offer to sell, distribute, […]
Summary Letters to four companies follow initial request to JUUL Labs as part of an ongoing effort to address youth use under the agency’s Youth Tobacco […]
A significant provision of the Family Smoking Prevention and Tobacco Control Act is the requirement for tobacco manufacturers to operate in compliance with current good manufacturing […]